Interestingly, blocking the PD-1/PD-L1 pathway was demonstrated to be beneficial in other brain pathologies, such as Progressive multifocal leukoencephalopathy in humans [87], and ischemic stroke in mice [88]. This evidence concerns the gene CD274 and ischemic stroke.